Exploring Patient Behaviour and Health Literacy in Drug Resistant Tuberculosis Therapy Program
Abstract
Background: Drug-resistant tuberculosis (MDR/RR-TB) requires a complex treatment regimen, such as BPaL (bedaquiline + pretomanid + linezolid) and BPaLM (with the addition of moxifloxacin), with a shortened duration of 6–9 months and cure rates of ≥90%. This study aimed to analyze the health literacy level of drug-resistant tuberculosis patients at Ngagelrejo Primary Health Center, Surabaya. Methods: The research employed a quantitative cross-sectional approach involving 30 TB-RO patients as respondents. Data were collected using the Health Literacy Questionnaire (HLQ) and analyzed through univariate and bivariate methods using the Chi-Square test. Results: The health literacy level of drug-resistant TB patients at the Ngagelrejo Community Health Center was in the fairly good category and showed a significant correlation with education level. However, there was no significant association between health literacy and age, gender, or medication adherence. Conclusion: These findings confirm that health literacy is a crucial component in managing drug-resistant TB therapy, despite that it does not play a sole role in determining adherence. To improve treatment success, health literacy strategies need to be directed toward a participatory, communicative, and technology-based approach.
How strong is the evidence?
Evidence Hub reads this as a cross-sectional, done in people. Its evidence level is 4 of 5 (Low · observational). Observational designs can show an association but not prove cause.
Read the paper
Related studies
- Synthesis, In Vitro and In Silico Molecular Docking Studies of Novel Phthalimide–Pyrimidine Hybrid Analogues to Thalidomide as Potent Antitubercular Agents
- Exploring the inhibitory performance of expired moxifloxacin and norfloxacin on copper corrosion in saline environment
- Molecular investigation of antimicrobial peptides against Helicobacter pylori proteins using a peptide-protein docking approach
- Screening of novel narrow-spectrum benzofuroxan derivatives for the treatment of multidrug-resistant tuberculosis through in silico, in vitro, and in vivo approaches
- Synthesis, Characterization, Anticancer, Antioxidant, and In Silico Evaluation of Semicarbazides and Thiosemicarbazides
- Fast and accurate prediction of drug induced proarrhythmic risk with sex specific cardiac emulators
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.